Durvalumab (anti-PD-L1)
Durvalumab (anti-PD-L1) is a selective, high affinity human IgG1 mAb that blocks programmed cell death ligand-1 (PD-L1) binding to PD-1 (IC50=0.1 nM) and CD80 (IC50=0.04 nM). MW=146.3 kDa.
| Trivial name | MEDI4736 |
| Catalog Number | A2013 |
| CAS# | 1428935-60-7 |
| Size | 1mg*5 |
| Supplier Page | http://www.selleckchem.com/products/durvalumab.html |